Menu
 

Search abstracts


The role of the hepatitis c pharmacist in managing complex drug-drug interactions

  • At: 2018 FIP Congress in Glasgow (Scotland)
  • Type: Poster
  • By: TORKINGTON, Adele (NORTH WEST ID UNIT @ NORTH MANCHESTER GENERAL HOSPITAL, Mrs)
  • Co-author(s): Adele Marie Torkington
    Sarah Cripps
    Karen Lee
    Anthony Pratt
    Paul Selby
    Katherine Davidson
    Susan Spollen
    Joyce Mahungu
    Helen Morgan
    Alison Boyle
    Tina Vaghijiani
    Fiona Marra
    Anja St.clair-jones
    Paul Gilvarry
    Sandeep Whitehead
  • Abstract:

    Background

    Directly active antivirals (DAA’s) are highly effective to cure Hepatitis C (HCV). However HCV patients have co-morbidities which complicate the most cost effective treatment of HCV as the DAA’s have many drug-drug interactions (DDIs) It is recommended that co-medicines are assessed for DDI before and during treatment. Clinical..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 13 May 2019

FIP Congresses